N-(5-Bromo-4-methylthiazol-2-yl)acetamide, 95+%, 250mg

6-Methyl-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 250mg

Ethyl 3-amino-2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)benzoate, 95.0%, 1g

4-Benzofuran-2-yl-thiazol-2-ylamine, 95.0%, 2.5g

1-Phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride, 95.0%, 250mg

Incubadora Heratherm Protocol series Protocolo general con convección natural, 117 l, IGS100, 1 pieza

N-a-(2,4-Dinitro-5-fluorophenyl)-L-alaninamide, 95.0%, 5g

2,5-Dichlorothiophene-3-carboxylic acid, 95.0%, 1g

1,5-Dioctadecyl N-(3-carboxy-1-oxopropyl)-L-glutamate, 98%, 1g

2-Bromobiphenyl, 98.0%, 10g

Piperazine, 1-(2-methoxyphenyl)-4-(trichloroacetyl)-, 98%, 5g

2-Thienyltrimethylsilane, 95%, 100g

(S,R,S)-AHPC-Me-C5-COOH, 50mg